We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Try the New Site
We're building a modernized ClinicalTrials.gov! Visit Beta.ClinicalTrials.gov to try the new functionality.

Key Record Dates

ClinicalTrials.gov Identifier: NCT05092360
Brief Title: Phase 3 Study of Nemvaleukin Alfa in Combination With Pembrolizumab in Patients With Platinum-Resistant Epithelial Ovarian Cancer (ARTISTRY-7) (ARTISTRY-7)

First Submitted : October 13, 2021
First Submitted that Met QC Criteria : October 13, 2021
First Posted : October 25, 2021

Last Update Submitted that Met QC Criteria : May 2, 2023
Last Update Posted : May 6, 2023